Pages that link to "Q46578408"
Jump to navigation
Jump to search
The following pages link to Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce l-dopa (Q46578408):
Displaying 50 items.
- Immortalization of neuronal progenitors using SV40 large T antigen and differentiation towards dopaminergic neurons (Q26829548) (← links)
- Prospects for new restorative and neuroprotective treatments in Parkinson's disease (Q28138668) (← links)
- Cellular replacement therapy for Parkinson's disease--where we are today? (Q28206557) (← links)
- Tyrosine hydroxylase and Parkinson's disease (Q28273702) (← links)
- Multipotent neural cell lines can engraft and participate in development of mouse cerebellum (Q28290006) (← links)
- A synopsis on the role of tyrosine hydroxylase in Parkinson's disease (Q28830946) (← links)
- Reversal of motor impairments in parkinsonian rats by continuous intrastriatal delivery of L-dopa using rAAV-mediated gene transfer (Q31045537) (← links)
- Viral vectors for gene therapy in Parkinson's disease (Q32113689) (← links)
- Successful survival of grafted transgenic neural plate cells in adult central nervous system environment (Q33541810) (← links)
- Human nerual stem cells for brain repair (Q33614725) (← links)
- Genetic regulatory elements introduced into neural stem and progenitor cell populations (Q33693779) (← links)
- Viral vectors in the treatment of Parkinson's disease (Q33816851) (← links)
- Gene therapy in the CNS. (Q33837123) (← links)
- Astrocyte line SVG-TH grafted in a rat model of Parkinson's disease (Q33939090) (← links)
- Approach to ex vivo gene therapy in the treatment of Parkinson's disease (Q34031071) (← links)
- Gene therapy for Parkinson's disease: review and update (Q34119491) (← links)
- Reconstruction of cortical circuitry (Q34120706) (← links)
- Encapsulated neural transplants (Q34120723) (← links)
- Improving the survival of grafted embryonic dopamine neurons in rodent models of Parkinson's disease (Q34120728) (← links)
- Gene delivery and gene therapy with herpes simplex virus-based vectors (Q34179305) (← links)
- Recombinant proteins for neurodegenerative diseases: the delivery issue (Q34338244) (← links)
- Gene therapy with herpes simplex virus vectors: progress and prospects for clinical neuroscience (Q34476794) (← links)
- Gene therapy for Parkinson's disease (Q34534274) (← links)
- Neurotrophic factors for the investigation and treatment of movement disorders (Q35165435) (← links)
- Oxidant exposure induces cysteine-rich protein 61 (CCN1) via c-Jun/AP-1 to reduce collagen expression in human dermal fibroblasts (Q35533275) (← links)
- Metabolic Engineering: Advances in Modeling and Intervention in Health and Disease (Q35550669) (← links)
- A novel approach to neural transplantation in Parkinson's disease: use of polymer-encapsulated cell therapy (Q35655515) (← links)
- Human neural stem cells genetically modified for brain repair in neurological disorders (Q35918287) (← links)
- Catecholaminergic neurons result from intracerebral implantation of embryonal carcinoma cells (Q36100649) (← links)
- Genetically modified cells: applications for intracerebral grafting (Q36705238) (← links)
- Subthalamic hGAD65 gene therapy and striatum TH gene transfer in a Parkinson's disease rat model (Q36853737) (← links)
- Intracerebral delivery of growth factors: Potential application of genetically modified fibroblasts (Q36928398) (← links)
- Selective brain penetrable Nurr1 transactivator for treating Parkinson's disease (Q36946543) (← links)
- Neural stem cell-based treatment for neurodegenerative diseases (Q38079295) (← links)
- Trophic factor gene therapy for Parkinson's disease (Q38079792) (← links)
- Brain transplantation of human neural stem cells transduced with tyrosine hydroxylase and GTP cyclohydrolase 1 provides functional improvement in animal models of Parkinson disease (Q40278367) (← links)
- Regulatable acetylcholine-producing fibroblasts enhance cognitive performance (Q40368732) (← links)
- Adenovirus vectors enter the brain (Q40489615) (← links)
- Clinical application of neuronal grafts in Parkinson's disease (Q40495990) (← links)
- Dynamics of transgene expression in a neural stem cell line transduced with lentiviral vectors incorporating the cHS4 insulator. (Q40533269) (← links)
- Activation of silenced transgene expression in neural precursor cell lines by inhibitors of histone deacetylation (Q40718965) (← links)
- Cells engineered to produce acetylcholine: therapeutic potential for Alzheimer's disease (Q40779642) (← links)
- Conditionally-immortalized astrocytic cell line expresses GAD and secretes GABA under tetracycline regulation (Q40882186) (← links)
- Reconstitution of a metabolic pathway with triple-cistronic IRES-containing retroviral vectors for correction of tetrahydrobiopterin deficiency (Q40886880) (← links)
- The Use of Nonneuronal Cells for Gene Delivery (Q40911146) (← links)
- Development of fetal hippocampal grafts in intact and lesioned hippocampus (Q40918373) (← links)
- Generation of tyrosine hydroxylase-producing neurons from precursors of the embryonic and adult forebrain (Q40952227) (← links)
- Applications of gene therapy to the CNS. (Q40957115) (← links)
- Dopamine turnover and metabolism in the striatum of parkinsonian rats grafted with genetically-modified human astrocytes (Q41035398) (← links)
- Neuronal progenitors as tools for cell replacement in the nervous system (Q41235622) (← links)